A look at how regulators are handling the surge in peptide use, from approved medicines like insulin and GLP-1 drugs to the wider market.
Recap by typeshit. Full story at Forbes.
A lawyer named Jeff walks through how his side argues Ozempic, Wegovy and other semaglutide drugs may be linked to NAION, a serious form of sudden vision loss.
Stavros Nicolaou of the Pharmaceutical Task Group wants police to act. SAHPRA says it has seized products and opened criminal cases.
The physician group is pushing back on an FDA plan that would open interim access to unapproved peptides, and wants the White House to block it.
Investigators turned up a warehouse of empty pens and a farm building used as a drug factory, as counterfeit weight loss injection sellers grow more organized.
Covers hair and nail findings, vision loss lawsuits both drugmakers dispute, and new WHO guidance against drug treatment for obesity in kids under 10.
Emory's Angela Haynes-Ferere and Cedars-Sinai's Amanda Velazquez say plateaus are common and advise seeing a doctor rather than stopping the drug.
Loading…